Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q2 Loss of 1c/Share

August 15, 2012 8:08 AM

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.

No results found